CHM
CHIMERIC FPO [CHM]
Healthcare · ASX Small Cap
$0.0020 +33.3%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +10First seen: 2026-02-25
Score Breakdown
Technical49
Catalyst53
Sentiment50
Fundamental27
Momentum39
Risk Gate20
Active Signals
Bullish Signals
- Stochastic bullish crossover (from low)
- Sustained volume spike (38.3x median) on DOWN trend
- VPT accumulation divergence (bullish)
- Low cash runway (3 quarters) - dilution risk
- Low P/S ratio (0.7x)
- EPS estimates revised downward (-10pts)
- Near 52-week low (7% of range)
- Micro-cap ($5-20M) - high risk
- Capital raise activity (1 events)
- Severe 12-1 momentum decline (-67%)
- Altman Z-Score in distress zone (1.30 < 1.81)
- Penny stock risk ($0.002)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE2 (est. )
Risk Signals
- Price below MAs (downtrend)
- Below 200-day MA (long-term downtrend)
- Piotroski F-Score weak (3/9)
- Deeply negative margins (-82%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Chimeric receives $1.8 M advance on FY26 R&D tax incentive
NONE Half Year Report and Appendix 4D 31 December 2025
NONE Portfolio streamlined - return of CHM CLTX to City of Hope
Announcement tone +3pts
Recent ASX Announcements
| 2026-03-01 | Chimeric receives $1.8 M advance on FY26 R&D tax incentive PRICE SENSITIVE |
| 2026-02-27 | Half Year Report and Appendix 4D 31 December 2025 PRICE SENSITIVE |
| 2026-02-26 | Portfolio streamlined - return of CHM CLTX to City of Hope PRICE SENSITIVE |
| 2026-02-25 | Revised response to ASX Query Letter |
| 2026-02-24 | Proposed issue of securities - CHM |
Key Metrics
$8.8M
Market Cap
7.4M
Avg Volume
38.3x
Vol Ratio
$0.00 — $0.01
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-469.4%
ROE
-82.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 58% |
| L | Leader vs Laggard | laggard | RS: -9 |
| I | Institutional Sponsorship | weak | Inst: 4% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #78 of 119 · Sector avg: 51
View all Healthcare signals →